Clinical Trial Update: User Acceptability of a Nicotine Lactate Delivery System (P3L) [NA]

View source ↗

Summary

Clinical trial update reporting user acceptability results for a nicotine lactate delivery system (P3L) in smoking, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• nicotine lactate delivery system (P3L) (nicotine lactate delivery system)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2019-06-20